This database contains 1058 studies, archived under the term: "aged"
Click here to filter this large number of results.
Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer’s disease patients
Albani, Diego,
Martinelli Boneschi, Filippo,
Biella, Gloria,
Giacalone, Giacomo,
Lupoli, Sara,
Clerici, Francesca,
Benussi, Luisa,
Ghidoni, Roberta,
Galimberti, Daniela,
Squitti, Rosanna,
Mariani, Stefania,
Confaloni, Annamaria,
Bruno, Giuseppe,
Mariani, Claudio,
Scarpini, Elio,
Binetti, Giuliano,
Magnani, Giuseppe,
Franceschi, Massimo,
Forloni, Gianluigi
Alzheimer’s disease (AD) is a neurodegenerative disorder often treated with donepezil, an acetylcholinesterase inhibitor. Response to donepezil is variable, probably based on patients’ genetic background in donepezil metabolizing enzymes, including cytochrome 2D6 (CYP2D6). We evaluated the association between clinical response to donepezil and a common variant (rs1080985) of CYP2D6, previously reported to be associated with […]
Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Aarsland, Dag,
Ballard, Clive,
Walker, Zuzana,
Bostrom, Fredrik,
Alves, Guido,
Kossakowski, Katja,
Leroi, Iracema,
Pozo-Rodriguez, Francisco,
Minthon, Lennart,
Londos, Elisabet
Background: Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are common forms of dementia that substantially affect quality of life. Currently, the only treatment licensed for PDD is rivastigmine, and there are no licensed treatments for DLB. We aimed to test the safety and efficacy of the N-methyl D-aspartate (NMDA) receptor antagonist memantine […]